Life Science Management

Part 1. Markets & Strategies.- Chapter 1. Development of the Life Sciences Industry Over the Past 30 Years.- Chapter 2. Venture Capital Perspectives on Life Science Innovation.- Chapter 3. Implications of Precision Medicine on Marketing & Sales Strategies.- Chapter 4. Intellectual Property in the Life Science Field - With a Focus on Patents.- Part 2. Technology & Data.- Chapter 5. How Ai Can Help Avoid Catastrophic Overload of Healthcare System in Times of a World-wide Pandemic.- Chapter 6. Event-driven Architecture for a Medical Records System.- Chapter 7. Hospitals of the Future - How Can We Get There?.- Part 3. Change & Innovation.- Chapter 8. Life Science Management as a Multi-disciplinary Challenge in Global Innovation Competition.- Chapter 9. Trust and Incentives in Driving a Collaborative Innovation - South Korean Life Science Industry.- Chapter 10. Drivers for Changes in the Evidence Generating Network for Biopharmaceuticals - the Impact of the Covid-pandemic.- Chapter 11. OpenInnovation in the Life Science Industry.- Part 4. Leaders & Entrepreneurs.- Chapter 12. Ludic Leadership: the Counter-intuitive Case for Playing Games in the Life Science Industry.- Chapter 13. Learning to Lead - a Non-profit Organization Perspective.- Chapter 14. Setting Up a Company in the Life Science Sector.

Avo Schönbohm is Professor for Business Administration at the Berlin School of Economics and Law / HWR Berlin (Germany) since 2010. His international research expertise lies in the areas of (strategic) performance management, enterprise gamification and digital transformation. He has authored more than 50 publications. International teaching assignments in Vietnam, Poland, France and Switzerland have enriched his teaching style and academic horizon. Prior to joining the HWR Berlin, Avo held various international roles in the machine tool industry, ending his pre-academic career as Vice President Strategic Planning at Voith Paper GmbH with 2bn EUR sales in 2010. With LUDEO he created a business agency in 2016 to bring game thinking into business life and thus enhance behaviour and performance of organisations in a variety of industries.
Hans Henning von Horsten is a Professor for Industrial Biomanufacturing at HTW-Berlin-University of Applied Sciences (Germany) and Founding Dean of the Faculty of Pharmaceutical Engineering and Technology at the German International University of Applied Sciences in Cairo (Egypt) . Currently, he is serving as the deputy manager for the Life Science Management study program at HTW Berlin. Prior to joining HTW-Berlin he was in charge of project and technology management within the Cell Line Development Business Unit of ProBioGen AG, an internationally operating Contract Development and Manufacturing Organization (CDMO) for the biopharmaceutical industry. In this role, he was among the key inventors of ProBioGen's GlymaxX antibody engineering technology that was outlicensed to Boehringer-Ingelheim, Novartis, Thermo-Fisher Scientific, Bayer, Roche, Abbvie and several other drug developers. He is co-inventor of several patents for the biomanufacturing business.
Philipp Plugmann has been doing multidisciplinary work for the last 20 years in parallel to practicing as a dentist in his own clinic in Leverkusen (Germany). He is also Full